Infant Bacterial Therapeutics AB (publ) reported earnings results for the second quarter and six months ended June 30, 2020. For the quarter, the company’s operating loss was SEK 27,915,000 against SEK 7,923,000 a year ago. Loss after tax was SEK 27,937,000 against SEK 7,561,000 a year ago. Loss per share before and after dilution was SEK 2.49 against SEK 0.67 a year ago. For the six months, the company’s operating loss was SEK 26,708,000 against SEK 8,766,000 a year ago. Loss after tax was SEK 26,759,000 against SEK 8,247,000 a year ago. Loss per share before and after dilution was SEK 2.38 against SEK 0.73 a year ago.